Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems
Authors:
- 21 March 2011
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 37 (10) , 1225-1230
Abstract
A new self-microemulsifying drug delivery system (SMEDDS) has been developed to increase the solubility, dissolution rate and oral bioavailability of tacrolimus (TAC). The formulations of TAC-SMEDDS were optimized by solubility assay, compatibility tests, and pseudo-ternary phase diagrams analysis. In order to inhibit the efflux of P-glycoprotein (P-gp) for tacrolimus, which is the substrate of P-gp, the excipients which show the inhibition effect to P-gp, such as tocopheryl polyethylene glycol succinate (TPGS) and Cremophor EL40, were chosen in the SMEDDS formulations. According to particle size and the rate of self-emulsification, two optimized formulations were selected: Miglyol 840 as oil phase, Transcutol P as cosurfactant, TPGS as surfactant (TPGS-SMEDDS) or Cremophor EL40 as surfactant (Crem-SMEDDS), respectively. The ratio of oil phase, surfactant and cosurfactant is 1:7.2:1.8. The mean droplet size distribution of the optimized SMEDDS was less than 20 nm. The in vitro dissolution test indicated a significant improvement in release characteristics of TAC. The prepared SMEDDS was compared with the homemade solution by administering the hard capsule to fasted rats. The absorption of TAC from TPGS-SMEDDS and Crem-SMEDDS form resulted in about sevenfold and eightfold increase in bioavailability compared with the homemade solution. Our study illustrated the potential use of SMEDDS for the delivery of hydrophobic compounds, such as TAC by the oral route.Keywords
This publication has 30 references indexed in Scilit:
- Vitamin E TPGS P-Glycoprotein Inhibition Mechanism: Influence on Conformational Flexibility, Intracellular ATP Levels, and Role of Time and Site of AccessMolecular Pharmaceutics, 2010
- Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Docetaxel microemulsion for enhanced oral bioavailability: Preparation and in vitro and in vivo evaluationJournal of Controlled Release, 2009
- Oral Bioavailability Enhancement of Acyclovir by Self-Microemulsifying Drug Delivery Systems (SMEDDS)Drug Development and Industrial Pharmacy, 2007
- A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticlesJournal of Controlled Release, 2005
- Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrineJournal of Pharmaceutical Sciences, 2004
- Modulation of Intestinal P-Glycoprotein Function by Cremophor EL and Other Surfactants by an In Vitro Diffusion Chamber Method Using the Isolated Rat Intestinal MembranesJournal of Pharmaceutical Sciences, 2004
- Lipid-Based Delivery Systems for Improving the Bioavailability and Lymphatic Transport of a Poorly Water-Soluble LTB4 InhibitorJournal of Pharmaceutical Sciences, 1998
- Clinical Pharmacokinetics of TacrolimusClinical Pharmacokinetics, 1995
- Transport of lipophilic molecules by the intestinal lymphatic systemAdvanced Drug Delivery Reviews, 1991